SCHEMBL21656101

SCHEMBL21656101

Cc1ccc2[nH]c3ccc4c5ccccc5sc4c3c2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KIF11 P52732 5/20 0.49
▸ MEN1 O00255 4/20 0.48
▸ KMT2A Q03164 4/20 0.48
▸ NPC1 O15118 2/20 0.48
▸ POLB P06746 1/20 0.48
▸ MAPT P10636 4/20 0.43
▸ RAB9A P51151 2/20 0.43
▸ TNKS O95271 2/20 0.42
▸ TNKS2 Q9H2K2 2/20 0.42
▸ GABRP O00591 2/20 0.42
▸ GABRD O14764 2/20 0.42
▸ GABRA1 P14867 2/20 0.42
▸ GABRB1 P18505 2/20 0.42
▸ GABRG2 P18507 2/20 0.42
▸ GABRB3 P28472 2/20 0.42
▸ GABRA5 P31644 2/20 0.42
▸ GABRA3 P34903 2/20 0.42
▸ GABRA2 P47869 2/20 0.42
▸ GABRB2 P47870 2/20 0.42
▸ GABRA4 P48169 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29470199 0.85 TNKS (0.57) KIF11MEN1KMT2AMAPTRAB9A
SCHEMBL31684 0.85 TNKS (0.57) KIF11MEN1KMT2AMAPTRAB9A
SCHEMBL29520199 0.85 TNKS (0.57) KIF11MEN1KMT2AMAPTRAB9A
SCHEMBL23351733 0.84 MEN1 (0.59) KIF11MEN1KMT2ANPC1POLB
SCHEMBL17117708 0.84 TNKS2 (0.43) KIF11MEN1KMT2ANPC1POLB
SCHEMBL16919355 0.83 MAPT (0.50) MEN1KMT2AMAPTRAB9ATNKS
SCHEMBL18630464 0.83 MAPT (0.43) KIF11MEN1KMT2AMAPTRAB9A
SCHEMBL14653493 0.83 TNKS (0.46) KIF11MEN1KMT2AMAPTRAB9A
SCHEMBL4554410 0.83 KDM4E (0.44) MEN1KMT2AMAPTRAB9ATNKS
SCHEMBL8817511 0.83 GABRP (0.45) MEN1KMT2AMAPTRAB9ATNKS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4190791-A1 COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT Kyulux, Inc. (JP) 2023-06-07 — — EP disclosed
US-20210143341-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2021-05-13 — — US disclosed
WO-2020022378-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE 出光興産株式会社 2020-01-30 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210143341-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE OR51E2, OR10J3, RER1 KIF11 2635/4885MEN1 1967/4885KMT2A 2010/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback